» Articles » PMID: 17588960

Reduced Cell Proliferation and Increased Apoptosis Are Significant Pathological Mechanisms in a Murine Model of Mild Pseudoachondroplasia Resulting from a Mutation in the C-terminal Domain of COMP

Overview
Journal Hum Mol Genet
Date 2007 Jun 26
PMID 17588960
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudoachondroplasia (PSACH) is one of the more common skeletal dysplasias and results from mutations in cartilage oligomeric matrix protein (COMP). Most COMP mutations identified to date cluster in the TSP3 repeat region of COMP and the mutant protein is retained in the rough endoplasmic reticulum (rER) of chondrocytes and may result in increased cell death. In contrast, the pathomolecular mechanism of PSACH resulting from C-terminal domain COMP mutations remain largely unknown. This study describes the generation and analysis of a murine model of mild PSACH resulting from a p.Thr583Met mutation in the C-terminal globular domain (CTD) of COMP. Mutant animals are normal at birth, but grow slower than their wild-type littermates and by 9 weeks of age they have mild short-limb dwarfism. Furthermore, by 16 months of age mutant animals exhibit severe degeneration of articular cartilage, which is consistent with early onset osteoarthritis seen in PSACH patients. In the growth plates of mutant mice the chondrocyte columns are sparser and poorly organized. Mutant COMP is secreted into the extracellular matrix, but its localization is disrupted along with the distribution of several COMP-binding proteins. Although mutant COMP is not retained within the rER there is an unfolded protein/cell stress response and chondrocyte proliferation is significantly reduced, while apoptosis is both increased and spatially dysregulated. Overall, these data suggests a mutation in the CTD of COMP exerts a dominant-negative effect on both intra- and extracellular processes. This ultimately affects the morphology and proliferation of growth plate chondrocytes, eventually leading to chondrodysplasia and reduced long bone growth.

Citing Articles

An Interesting Case of Multiple Epiphyseal Dysplasia Masquerading as Myopathy in a Southeast Asian Girl.

Swaroop S, Srivastava P, Diwakar K, Laik J, Mishra M, Anand R Cureus. 2025; 17(2):e78400.

PMID: 40046393 PMC: 11880794. DOI: 10.7759/cureus.78400.


Thrombospondins: Conserved mediators and modulators of metazoan extracellular matrix.

Adams J Int J Exp Pathol. 2024; 105(5):136-169.

PMID: 39267379 PMC: 11574667. DOI: 10.1111/iep.12517.


FicD sensitizes cellular response to glucose fluctuations in mouse embryonic fibroblasts.

Gulen B, Blevins A, Kinch L, Servage K, Stewart N, Gray H Proc Natl Acad Sci U S A. 2024; 121(38):e2400781121.

PMID: 39259589 PMC: 11420183. DOI: 10.1073/pnas.2400781121.


Structure, evolution and expression of zebrafish cartilage oligomeric matrix protein (COMP, TSP5). CRISPR-Cas mutants show a dominant phenotype in myosepta.

Forte-Gomez H, Gioia R, Tonelli F, Kobbe B, Koch P, Bloch W Front Endocrinol (Lausanne). 2022; 13:1000662.

PMID: 36452329 PMC: 9702538. DOI: 10.3389/fendo.2022.1000662.


Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities.

Cui J, Zhang J Int J Mol Sci. 2022; 23(16).

PMID: 36012514 PMC: 9408827. DOI: 10.3390/ijms23169253.


References
1.
Schmitz M, Becker A, Schmitz A, Weirich C, Paulsson M, Zaucke F . Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. J Biol Chem. 2006; 281(43):32587-95. DOI: 10.1074/jbc.M601976200. View

2.
Oldberg A, Antonsson P, LINDBLOM K, Heinegard D . COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem. 1992; 267(31):22346-50. View

3.
Rimoin D, Rasmussen I, Briggs M, Roughley P, Gruber H, Warman M . A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix. Hum Genet. 1994; 93(3):236-42. DOI: 10.1007/BF00212015. View

4.
DiCesare P, Morgelin M, Mann K, Paulsson M . Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem. 1994; 223(3):927-37. DOI: 10.1111/j.1432-1033.1994.tb19070.x. View

5.
Bornstein P, Sage E . Thrombospondins. Methods Enzymol. 1994; 245:62-85. DOI: 10.1016/0076-6879(94)45006-4. View